Pelthos Therapeutics Inc. (PTHS) Financials

PTHS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 145.4 million 110.3 million
Dec. 31, 2025 130.4 million 91.5 million
Sept. 30, 2025 126.4 million 68.2 million
June 30, 2025 822850 7.3 million

PTHS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -13.3 million 1.9 million
Dec. 31, 2025 -6.4 million 1.8 million
Sept. 30, 2025 -15.3 million 2.8 million
June 30, 2025 -447145 413486

PTHS Net Income

No data available :(

PTHS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 32.2 million 49.6 million 2.7 million
Dec. 31, 2025 18.0 million 31.4 million 2.8 million
Sept. 30, 2025 14.3 million - 2.8 million
June 30, 2025 59172 - -

PTHS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 3.3 million
Dec. 31, 2025 3.2 million
Sept. 30, 2025 640518
June 30, 2025 640518

PTHS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 194000 186000 20.6 million -
Dec. 31, 2025 99000 374000 18.1 million -
Sept. 30, 2025 - 145000 19.2 million -
June 30, 2025 5 514814 2.7 million -

PTHS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 10.9 million 3.2 million
Dec. 31, 2025 9.4 million 2.9 million
Sept. 30, 2025 7.4 million 3.4 million
June 30, 2025 - -

PTHS

Price: $27.40

52 week price:
16.09
54.29

Earnings Per Share: -22.92 USD

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 16.7 million

Links: